Literature DB >> 3663019

Energetic aspects of inotropic interventions in rat myocardium.

G Hasenfuss1, C Holubarsch, H Just, E Blanchard, L A Mulieri, N R Alpert.   

Abstract

Contractile force of the myocardium can be increased by different molecular mechanisms, and therefore different energetic consequences may result. The influence of the inotropic substances isoproterenol and UDCG-115 on myocardial energetics in isometrically contracting left ventricular rat papillary muscles was investigated by means of highly sensitive antimony bismuth thermopiles. Isoproterenol increased total heat and initial heat by 147% (p less than 0.01) and 69% (p less than 0.02) when normalized to tension-time integral, respectively. No significant change of both heat terms occurred due to UDCG-115. Initial heat was separated into tension-independent heat ("calcium cycling") and tension-dependent heat ("cross-bridge cycling") by means of a new method using 2,3-butanedione monoxime. Both tension-dependent heat per tension-time integral and tension-independent heat increased significantly, due to isoproterenol, from 4.9 +/- 1.17 to 7.6 +/- 2.72 mu cal/g.cm.s (p less than 0.05) and from 0.15 +/- 0.06 to 0.22 +/- 0.04 mcal/g (p less than 0.01). UDCG-115 influenced neither tension-independent heat nor tension-dependent heat per tension-time integral significantly. Thus, the economy of force development was not significantly altered due to UDCG-115 whereas isoproterenol significantly increased the energy necessary for activation, i.e. calcium cycling, and the energy necessary for force production, i.e. cross-bridge cycling. The basic mechanisms of these energetic changes are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663019     DOI: 10.1007/978-3-662-11289-2_24

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  7 in total

Review 1.  Calcium sensitisers.

Authors:  J A Lee; D G Allen
Journal:  BMJ       Date:  1990-03-03

2.  Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations.

Authors:  G Hasenfuss; C Holubarsch; E M Blanchard; L A Mulieri; N R Alpert; H Just
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

Review 3.  Levosimendan.

Authors:  D P Figgitt; P S Gillies; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

5.  Tension-dependent and tension-independent energy components of heart contraction.

Authors:  J E Ponce-Hornos; P Bonazzola; F D Marengo; A E Consolini; M T Márquez
Journal:  Pflugers Arch       Date:  1995-04       Impact factor: 3.657

6.  Similar oxygen cost of myocardial contractility between DPI 201-106 and epinephrine despite different subcellular mechanisms of action in dog hearts.

Authors:  S Futaki; Y Goto; Y Ohgoshi; H Yaku; H Suga
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

7.  Haemodynamic dose-efficacy of levosimendan in healthy volunteers.

Authors:  J Lilleberg; S Sundberg; M Häyhä; J Akkila; M S Nieminen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.